BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15855531)

  • 41. Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells.
    Hardy RW; Marcotrigiano J; Blight KJ; Majors JE; Rice CM
    J Virol; 2003 Feb; 77(3):2029-37. PubMed ID: 12525637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents.
    Shakya N; Vedi S; Liang C; Yang F; Agrawal B; Kumar R
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1407-9. PubMed ID: 24485784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and anti-hepatitis C virus activity of 2'(beta)-hydroxyethyl and 4'(alpha)-hydroxymethyl carbodine analogues.
    Liu LJ; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2009 Nov; 28(11):1007-15. PubMed ID: 20183569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties.
    Kirschberg TA; Metobo S; Clarke MO; Aktoudianakis V; Babusis D; Barauskas O; Birkus G; Butler T; Byun D; Chin G; Doerffler E; Edwards TE; Fenaux M; Lee R; Lew W; Mish MR; Murakami E; Park Y; Squires NH; Tirunagari N; Wang T; Whitcomb M; Xu J; Yang H; Ye H; Zhang L; Appleby TC; Feng JY; Ray AS; Cho A; Kim CU
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1840-1847. PubMed ID: 28274633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and anti-HCV evaluation of 4'(alpha)-ethyl and 2'(beta)-methyl-carbodine analogues.
    Li H; Yoo JC; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2009 Sep; 28(9):809-20. PubMed ID: 20183620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of optically pure dioxolanes as inhibitors of hepatitis C virus RNA replication.
    Bera S; Malik L; Bhat B; Carroll SS; MacCoss M; Olsen DB; Tomassini JE; Eldrup AB
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4455-8. PubMed ID: 14643345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro.
    Lu L; Dekhtyar T; Masse S; Pithawalla R; Krishnan P; He W; Ng T; Koev G; Stewart K; Larson D; Bosse T; Wagner R; Pilot-Matias T; Mo H; Molla A
    Antiviral Res; 2007 Oct; 76(1):93-7. PubMed ID: 17561278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 6-Hydrazinopurine 2'-methyl ribonucleosides and their 5'-monophosphate prodrugs as potent hepatitis C virus inhibitors.
    Gunic E; Chow S; Rong F; Ramasamy K; Raney A; Li DY; Huang J; Hamatake RK; Hong Z; Girardet JL
    Bioorg Med Chem Lett; 2007 May; 17(9):2456-8. PubMed ID: 17331718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094.
    Ehteshami M; Tao S; Ozturk T; Zhou L; Cho JH; Zhang H; Amiralaei S; Shelton JR; Lu X; Khalil A; Domaoal RA; Stanton RA; Suesserman JE; Lin B; Lee SS; Amblard F; Whitaker T; Coats SJ; Schinazi RF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4659-69. PubMed ID: 27216050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. INX-08189, a phosphoramidate prodrug of 6-O-methyl-2'-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties.
    Vernachio JH; Bleiman B; Bryant KD; Chamberlain S; Hunley D; Hutchins J; Ames B; Gorovits E; Ganguly B; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters CR; Wang J; Williams K; Patti JM; Henson G; Madela K; Aljarah M; Gilles A; McGuigan C
    Antimicrob Agents Chemother; 2011 May; 55(5):1843-51. PubMed ID: 21357300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.
    Eldrup AB; Allerson CR; Bennett CF; Bera S; Bhat B; Bhat N; Bosserman MR; Brooks J; Burlein C; Carroll SS; Cook PD; Getty KL; MacCoss M; McMasters DR; Olsen DB; Prakash TP; Prhavc M; Song Q; Tomassini JE; Xia J
    J Med Chem; 2004 Apr; 47(9):2283-95. PubMed ID: 15084127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity.
    Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Hofmann GA; Slater MJ; Haigh D; Dhanak D; Johnson VK; Parry NR; Thommes P
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1930-3. PubMed ID: 17270443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
    Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates.
    Shi J; Zhou L; Zhang H; McBrayer TR; Detorio MA; Johns M; Bassit L; Powdrill MH; Whitaker T; Coats SJ; Götte M; Schinazi RF
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7094-8. PubMed ID: 22014549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus.
    Lai VC; Dempsey S; Lau JY; Hong Z; Zhong W
    J Virol; 2003 Feb; 77(3):2295-300. PubMed ID: 12525668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus.
    Sofia MJ; Bao D; Chang W; Du J; Nagarathnam D; Rachakonda S; Reddy PG; Ross BS; Wang P; Zhang HR; Bansal S; Espiritu C; Keilman M; Lam AM; Steuer HM; Niu C; Otto MJ; Furman PA
    J Med Chem; 2010 Oct; 53(19):7202-18. PubMed ID: 20845908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase.
    Chapron C; Glen R; La Colla M; Mayes BA; McCarville JF; Moore S; Moussa A; Sarkar R; Seifer M; Serra I; Stewart A
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2699-702. PubMed ID: 24815510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New furano- and pyrrolo[2,3-d]pyrimidine nucleosides and their 5'-triphosphates: synthesis and biological properties].
    Ivanov MA; Ivanov AV; Krasnitskaia IA; Smirnova OA; Karpenko IL; Belanov EF; Prasolov VS; Tunitskaia VL; Aleksandrova LA
    Bioorg Khim; 2008; 34(5):661-70. PubMed ID: 19060941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical and biological effects of substitution of the 2-position of ring-expanded ('fat') nucleosides containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system: the role of electronic and steric factors on glycosidic bond stability and anti-HCV activity.
    Zhang P; Zhang N; Buckwold VE; Hosmane RS
    Bioorg Med Chem; 2007 Jul; 15(14):4933-45. PubMed ID: 17507230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture.
    Stuyver LJ; Whitaker T; McBrayer TR; Hernandez-Santiago BI; Lostia S; Tharnish PM; Ramesh M; Chu CK; Jordan R; Shi J; Rachakonda S; Watanabe KA; Otto MJ; Schinazi RF
    Antimicrob Agents Chemother; 2003 Jan; 47(1):244-54. PubMed ID: 12499198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.